Contineum Therapeutics Stock (NASDAQ: CTNM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 125.056K |
Day Range | - - - |
52 Wk Range | 13.270 - 16.090 |
Market Cap | $377.213M |
P/E Ratio | 22.222 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | - |
Days to Cover | 11.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Contineum Therapeutics (NASDAQ: CTNM) through any online brokerage.
Other companies in Contineum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
The latest price target for Contineum Therapeutics (NASDAQ: CTNM) was reported by Stifel on Tuesday, April 30, 2024. The analyst firm set a price target for 29.00 expecting CTNM to rise to within 12 months (a possible 93.20% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $15.01 last updated May 15, 2024 at 5:25 PM EDT.
There are no upcoming dividends for Contineum Therapeutics.
Contineum Therapeutics’s Q3 earnings are confirmed for Friday, August 16, 2024.
There is no upcoming split for Contineum Therapeutics.
Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.